Details for 2012759802

Up to date per 01.04.2026

Actions

Title / Product Name

NEUE (TRIMETHOXYPHENYLAMINO-)PYRIMIDINYL-FORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012759802

EP Publication Number

2736487

E-Number

1061233

Language

PCT Number

GB12051791

Publication Date

04.06.2014 A

07.11.2018 B1

Registration Date

07.11.2018

AT Publication Date

15.11.2018

Application Date

26.07.2012

Registration Number

Priorities

28.07.2011

201161512621 P

IPC

A61K 9/00 20060101AFI20180420BHEP

Maximum Duration of Protection

26.07.2032

Owner

Rigel Pharmaceuticals, Inc.1180 Veterans Boulevard South San Francisco, CA 94080US

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

ALHUSBAN, Farhan, Abdul, KarimAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

GABBOTT, Ian, PaulAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

GURURAJAN, BindhumadhavanAstraZeneca R&D Mölndal 431 83 MölndalSE

SIEVWRIGHT, DawnAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

SIMPSON, David, Bradley, BrookAstraZeneca Charter Way Macclesfield Cheshire SK10 2NAGB

Information about Fees